Gait Analysis of Hemiparetics Adults Patients With Quadripod Cane and Rolling Cane

Sponsor

University of Liege (Other)

Overall Status

Recruiting

CT.gov ID

NCT05163444

Collaborator

(none)

Enrollment

Locations

Arms

13.1

Anticipated Duration (Months)

Patients Per Site

1.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

After stroke, a lot of patients present an hemiparesis and gait disorders. They need walking aids like quadripod cane or rolling cane.

The quadripod cane confers a great stability but implies a walk in 3 times, thus consume more energy. The pause time necessary for the displacement (uplift) of the cane disappear with the Wheeleo.

The investigators will study many spatio-temporal parameters to determine which one allows to decrease the walking speed.

Condition or Disease	Intervention/Treatment	Phase
Stroke Hemiplegic Gait	Device: Gait analysis with rolling cane Device: Gait analysis with quadripod cane	N/A

Detailed Description

Hemiparesis affects 65% of stroke patients and cause gait disorders. During rehabilitation, patients often need technical aids to the the return to walk.

For example, they can use the quadripod cane and the rolling cane, called Wheeleo. Regarding the first one, as its name indicate, there are 4 feet while the other model has 4 wheels.

Deltombe and al. proved that the walking speed is higher with a rolling cane. The investigators will recruited stroke patients and study many spatio-temporal parameters with a gait analysis system, when participants are walking with the two walking aids.

Participants will achieve 6 minutes walking test and a 10 meters walking test, with a wearable inertial systems on their shoes.

The investigators wish to reveal which spatio-temporal parameters most influence walking speed.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

30 participants

Allocation:

Randomized

Intervention Model:

Crossover Assignment

Intervention Model Description:

Clinical trial, randomized, crossoverClinical trial, randomized, crossover

Masking:

None (Open Label)

Primary Purpose:

Other

Official Title:

Gait Analysis of Hemiparetics Adults Patients With Quadripod Cane and Rolling Cane

Actual Study Start Date :

Feb 26, 2022

Anticipated Primary Completion Date :

Mar 31, 2023

Anticipated Study Completion Date :

Mar 31, 2023

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Rolling can Gait analysis with rolling cane	Device: Gait analysis with rolling cane 6 minutes walking test 10 meters walking test Before this experimentation, we will fix wearables sensors on the shoes.
Active Comparator: Quadripod can Gait analysis with quadripod cane	Device: Gait analysis with quadripod cane 6 minutes walking test 10 meters walking test Before this experimentation, we will fix wearables sensors on the shoes.

Arm

Intervention/Treatment

Experimental: Rolling can

Gait analysis with rolling cane

Device: Gait analysis with rolling cane

6 minutes walking test 10 meters walking test Before this experimentation, we will fix wearables sensors on the shoes.

Active Comparator: Quadripod can

Gait analysis with quadripod cane

Device: Gait analysis with quadripod cane

6 minutes walking test 10 meters walking test Before this experimentation, we will fix wearables sensors on the shoes.

Outcome Measures

Primary Outcome Measures

10 meters walking test at fast speed [2 days]
Calculate the walking speed

Secondary Outcome Measures

6 minutes walking test at spontaneous speed [2 days]
Spatio-temporals factors analysis (symmetry, time of unipodal/bipodal stance station,...)

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Age > 18 years
Hemiparesis following a stroke
Be able to walk with a quadripod cane independently
Be able to walk with the rolling cane independently
Be able to follow instructions

Exclusion Criteria:

cognitive impairment
acute orthopedic impairment
other pathologies affecting walking (Parkinson's disease, severe polyneuropathy,...)

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHUOA	Esneux	Liege	Belgium	4130
2	CNRF	Tinlot	Liege	Belgium	4557

Sponsors and Collaborators

University of Liege

Investigators

Principal Investigator: Berengere Maillard, University of Liege

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Maillard Berengere, Principal Investigator, University of Liege

ClinicalTrials.gov Identifier:

NCT05163444

Other Study ID Numbers:

Liege Hospital Ethic Comittee

First Posted:

Dec 20, 2021

Last Update Posted:

May 24, 2022

Last Verified:

May 1, 2022

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Gait Disorders, Neurologic

Study Results

No Results Posted as of May 24, 2022